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Purpose: To investigate the effects of acute caffeine (CAFF) intake on physical performance in elite women handball players.
Methods: A total of 15 elite women handball players participated in a randomized, double-blind study. In 2 different trials,
participants ingested either a placebo (cellulose) or 3 mg of CAFF per kilogram of body mass (mg/kg/bm) before undergoing a
battery of neuromuscular tests consisting of handball throws, an isometric handgrip strength test, a countermovement jump, a 30-
m sprint test (SV), and a modified version of the agility T test. Then, participants performed a simulated handball game
(2 × 20 min), and movement patterns were recorded with a local positioning system. Results: Compared with the placebo, CAFF
increased ball velocity in all ball throws (P = .021–.044; Effect size [ES] = 0.39–0.49), strength in isometric handgrip strength test
(350.8 [41.2] vs 361.6 [46.1] N, P = .034; ES = 0.35), and countermovement jump height (28.5 [5.5] vs 29.8 [5.5] cm; P = .006;
ES = 0.22). Besides, CAFF decreased running time in the SV (4.9 [0.2] vs 4.8 [0.3] s; P = .042; ES = −0.34). In the simulated
game, CAFF increased the frequency of accelerations (18.1 [1.2] vs 18.8 [1.0] number/min; P = .044; ES = 0.54), decelerations
(18.0 [1.2] vs 18.7 [1.0] number/min; P = .032; ES = 0.56), and body impacts (20 [8] vs 22 [10] impacts/min; P = .032;
ES = 0.30). However, postexercise surveys about self-reported feelings of performance indicate that players did not feel increased
performance with CAFF.Conclusion: Preexercise ingestion of 3mg/kg/bm of CAFF improved ball throwing velocity, jump, and
sprint performance and the frequency of in-game accelerations and decelerations in women elite handball players.
Keyword:Q1 nutrition
Handball is an intermittent team sport, which is characterized
by high-intensity actions, such as accelerations and decelerations,
fast changes of direction, running sprints, and collisions with
opponents.1,2 At the elite level, women handball players cover
∼4000 m during a match while high-intensity running constitutes
∼2.5% of the total distance covered (ie, ∼100 m).3Women handball
players spend a considerable amount of energy in actions involving
accelerations and decelerations as these actions are always per-
formed in offensive and defensive in-game situations close to the
goal zone.1–3 Although handball has similarities with other team
sports, such as basketball, football, and hockey, the unlimited
number of substitutions allow players to occupy specific roles
for attacking and defending. Interestingly, the time spent at high-
intensity running and the frequency of demanding actions are
typically reduced from the first to the second half, which indicates
that physical performance in elite handball might be impaired
toward the end of the game.4 All this information indicates that
high-intensity actions are critical for overall handball success, and
because of this, the strategies to improve elite handball players’
physical performance have attracted handball strength and condi-
tioning coaches’ and researchers’ attention.5,6
Given the explosive demands that characterize handball com-
petition, identification of nutritional aids that might contribute to
the improvement of physical performance during training or
matches could be an interesting strategy to be adopted by elite
handball players.7 However, despite the popularity of handball, the
information about nutritional strategies to increase handball per-
formance is scarce, in particular caffeine (CAFF). In fact, only one
investigation has determined the effects of acute CAFF intake on
handball performance7 despite the fact that the postmatch urinary
concentrations of elite handball players suggest a common use of
this substance in competition.8
Caffeine (1,3,7-trimethylxanthine) is a substance rapidly ab-
sorbed by the body because it appears in the blood within 5 to
15 min, reaching peak blood concentration between 45 and 60 min
after ingestion.9 Although several mechanisms have been proposed
for the increased physical performance after acute CAFF intake,
there is a consensus about the antagonism of CAFF on the
adenosine receptors (ie, blocking the “fatiguing” action of adeno-
sine) as the main mechanism behind the performance-enhancing
effect of this substance.10,11 The preexercise ingestion of 3 to 9 mg
of CAFF per kilogram of bodymass (mg/kg/bm) has the capacity to
improve performance in a wide variety of team sports,12 and there is
evidence of the ergogenicity of CAFF in basketball,13 rugby,14
volleyball,15 and football16,17 matches. Previous investigations
have found that in addition to the effects of CAFF on physical
performance, it was also effective to enhance the execution of team
sport-specific actions such as shooting13 and passing accuracy18
that might end in a higher overall players’ performance index.13,15
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As a result, CAFF has been catalogued as an ergogenic aid for ball
games although the risk-benefit ratio of CAFF ingestion should be
contrasted in the light of the characteristics of each sport19,20 and
accounting for the side effects it produces.21 Particularly, CAFF
intake has been associated to an increased prevalence of nervous-
ness and insomnia after exercise,21 which might affect those
disciplines with matches played on consecutive days.
Ribeiro et al7 studied the effects of CAFF ingestion (6 mg/kg/
bm) in 6 handball players who performed 4 × 30 s of continuous
vertical jumps. These authors found that CAFF improved leg
power during jumping by ∼5% with no higher levels of exer-
cise-induced muscle damage. However, the unspecific nature of
this jumping test for overall handball performance and the low
sample size used in this investigation preclude ascertaining whether
CAFF is ergogenic for the particular characteristics of handball.
Thus, the aim of this study was to determine if the ingestion of




A total of 15 elite women handball players (age 22.6 [3.6] y, height
1.70 [0.08] m, body mass 69.5 [9.5] kg, handball experience 11.0
[2.7] y) from the same handball team (ie, first division of the Spanish
National League) participated in this study. All participants were
considered as low-CAFF consumers (50 [30] mg/d). Elite women
handball players between 18 and 40 y old were eligible for inclusion.
Exclusion criteria were intolerance to CAFF, suffering from any
chronic pathology or an injury in the month prior to the investigation,
a habitual consume of CAFF >100 mg/d, and the use of medicines or
dietary supplements during the study. All the recruited participants
were low-CAFF consumers, <100 mg/d of CAFF, measured with a
valid semiquantitative CAFF intake questionnaire.22 Ten participants
were tested during the follicular phase of their menstrual cycle, and
5were tested during the luteal phase according to amobile application
(MycalendarQ3
®; Period Tracker) that identifies main events occurring
during the menstruation cycle.23 Participants gave their informed
written consent to participate, and the study was approved by the
UniversityQ4 Ethics Committee (number 22/2019) in accordance with
the Declaration of Helsinki.
Experimental Design
A randomized, double-blind, placebo-controlled crossover experi-
ment was used. Each player underwent 2 identical experimental
trials, separated by a week to allow recovery and substances
washout. In each trial, participants ingested an unidentifiable
gelatine capsule with either CAFF (3 mg/kg/bm; Bulk Powders
100% purityQ5 , United Kingdom) or an inert substance (Cellulose;
GuinamaQ6 , Spain). The dose of CAFF was selected to replicate the
treatment used in previous investigations with team-sport women
athletes.14,15,17 Capsule was ingested with 100 mL of water and
60 min before the onset of the experiment to allow substances
absorption. Then, participants performed a set of physical assess-
ments, as explained later, to determine the effects of CAFF on
several aspects of handball physical performance. In both trials, the
experimental procedures were performed at the same time of day to
avoid the influence of circadian rhythms on performance.24 Air
temperature and humidity were monitored during both trials with a
portable weather station (Meteorological Station, Küken, Spain).
Experimental Protocol
During the 24 h prior to testing, participants were encouraged to
refrain from all dietary sources of CAFF and strenuous exercise.
They were instructed to consume the same meals the day before
each trial. On trial days, participants arrived at their habitual
training facility—indoor court—at 18:00 h. Then, body compo-
sition (Tanita B-601; Tanita Corp, Tokyo, Japan) and tympanic
temperature (Thermoscan 7-IRT 6520; Braun Q7, Germany) were
measured to assure similar conditions before each trial. After
this, the assigned experimental capsule was ingested, and inges-
tion was verified by an experimenter. Participants performed a
20-min standardized warm-up, and just 60 min after capsule
ingestion, they underwent a battery of physical performance tests
consisting of several types of ball throws (BT; from 7 m to 9 m
with and without opposition), a countermovement jump (CMJ),
an isometric handgrip strength test (IHS), a modified version of
the agility T test (MATT), and a 30-m maximal running velocity
test Q8(SV). A 5-min resting period was set among test to allow
recovery. One week before the onset of the experiment, a
familiarization session that included the execution of all these
tests was carried out. Ten minutes after this handball-specific
testing, participants played a 2 × 20-min simulated hand-
ball match.
Handball-Specific BT
Players performed 2 types of BT, always at maximal velocity one
from the penalty line (7 m) and the other one from behind 9-m line.
For the 7-m throw, the test followed the rules for the penalty throw
in handball. For the 9-m throw, a 3-step run and a vertical jump
behind the 9-m line preceded the throw to simulate an in-game
throw.2,25 Each BTwas executed with and without the presence of a
goalkeeper (GK). The tests were carried out in the following order:
7 m, 7 m with GK, 9 m, and 9 m with GK. A 60-s rest was set
between BT. A sports radar gun (Pocket Radar Ball Coach
PR1000-BC Q9, Republic of South Korea), held by an experimenter
placed 2 m behind the players, was used to record maximal ball
velocity. The mean value of the 3 attempts was annotated as
previously reported in other intermittent sports.25
IHS and CMJ
Maximal IHS was measured in the dominant hand using a cali-
brated handgrip dynamometer (Takei 5101 Q10, Tokyo, Japan) as
previously reported.26 The highest value out of 2 attempts was
recorded and used for statistical analysis. Afterward, participants
completed 2 repetitions of a maximal CMJ test with hands on the
hips while jump height was measured using an infrared-beams
jump system (Optojump Next, Microgate Q11, Italy). The 2 CMJ
attempts were interspersed with 45 s of passive recovery as
previously described.27 The highest jump was used for statistical
analysis. Good reliability of IHS (CV Q12= 4.1%) and CMJ
(CV = 3.2%) has been previously reported.27
SV and MATT
In the SV test, participants ran at maximal speed for 30 m in a
straight line, and the time needed to cover the distance was
measured using 2 photocell gates placed 1 m above the Q13ground
(SMARTSPEED; Fusion Sport Q14, Australia). This test was selected
based on a previous investigation with elite female handballers2
and because it might represent the distance covered during a fast
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break.28 Each sprint was initiated from a standing position, 1 m
behind the photocell gate. The digital timer was automatically
initiated when the player crossed the first gate, and it was stopped
when the players crossed the gate placed 30 m ahead at the finish
line. The best performance out of 2 repetitions was recorded for
subsequent analysis, and a 2-min resting period was allowed
between repetitions. Afterward, the MATT was conducted using
the protocol outlined by Sassi et al.29 Two electronic time sensors
(SMARTSPEED; Fusion Sport) were set 1 m above the ground and
positioned 3 m apart facing each other on either side of the start or
finish line. The best performance out of 2 repetitions (separated by
a 2-min recovery period) was recorded for subsequent analysis.
Good reliability of SV (CV = 2.6%) and MATT (CV = 1.2%) has
been previously reported.27
Simulated Handball Match
Ten minutes after the end of the handball-specific testing, players
participated in a simulated game played on an official indoor
handball court and following the rules of the International Hand-
ball Federation (except for the game duration). The game con-
sisted of 2 parts of 20 min with a break of 5 min between them. All
players were equipped with an inertial measurement unit based on
ultra-wideband position tracking system technology (WIMU-
PROTM; RealTrack SystemsQ15 , Almería, Spain; CV = 2.5%–
3.5%),30 which was introduced on a lycra vestQ16 to place the inertial
measurement unit between the shoulders. A heart rate monitor
(Garmin™ Heart Rate BandQ17 ) was then firmly attached to their
chest. The inertial measurement unit devices were calibrated and
installed around the court as previously described31 and obtained
data with a frequency of 100 Hz. During these games, player’s
substitutions were standardized, and all variables were normalized
by each participant’s playing time. The distance covered was in
total and categorized afterward in 5 speed zones stationary/
walking (<6.0 km/h), jogging (6.0–12.0 km/h), running (12.1–
18.0 km/h), high-intensity running (18.1–24.0 km/h), and sprint-
ing (>24.1 km/h). In addition, the number of accelerations (total
and zone 1 [0–1 m/s2], zone 2 [1–2 m/s2], zone 3 [2–3 m/s2], and
zone 4 [3–4 m/s2]) and the total number of decelerations were
recorded (total zone 1 [0 to 1 m/s2], zone 2 [−1 to 2 m/s2], zone 3
[−2 to 3 m/s2], and zone 4 [−3 to 4 m/s2]). Impact intensity was
graded according to the following scale: zone 1 from 0 to ≤5 g,
zone 2 from 5 to ≤8 g, and zone 3 from 8 to ≤10 g.
Questionnaire
At the end of the simulated match, players were required to fill out
a questionnaire about their feelings of muscle power, endurance,
and overall perceived exertion during the game, as previously
reported.21 In addition, the morning following the study the
participants filled out another questionnaire based on the main
side effects associated with CAFF during the hours after the
game.21
Environmental Conditions and Tympanic
Temperature
During the testing sessions, air temperature (14.2°C [2.8°C]) and
relative humidity (40% [2%]) were similar on both days. No
differences were reported in tympanic temperature (36.7°C
[0.3°C] vs 36.9°C [0.3°C]; P = .100) between the different
days.
Statistical Analysis
Data are presented as mean Q18(SD). Normality of each variable was
tested using the Shapiro–Wilk test. Differences between experi-
mental conditions (CAFF vs placebo) were determined using
paired t tests, and differences were considered as statistically
relevant at P < .05. Effect size (ES) and 95% confidence interval
(CI) were also calculated in all pairwise comparisons, whereas ES
was interpreted using Cohen categorization.32 Differences between
experimental conditions in the 1- to 10-point scale used for the
self-reported feelings of muscle power, endurance, and overall
perceived exertion during the game were identified using the
Wilcoxon signed-rank test. The McNemar test was also used to
detect differences in the prevalence of side effects. Data analysis
was performed using SPSS (version 22.0; SPSS Inc, Chicago, IL).
Results
Handball-Specific BT
In comparison with the placebo, ball velocity was higher with
CAFF in all the BT tests in a range of improvement of 2.2% to
3.6%. Specifically, CAFF increased ball velocity in the 7-m throw
(P = .021; ES = 0.39; 95% CI, 0.07 to 0.71), in the 7 m + GK
throw (P = .039; ES = 0.44; 95%CI, 0.03 to 0.86), in the 9-m throw
(P = .044; ES = 0.49; 95% CI, 0.01 to 0.96), and in the 9 m + GK
throw (P = .023; ES = 0.45; 95% CI, 0.07 to 0.83) (Figure 1).
IHS and CMJ
The IHS in the dominant hand was 3.3% (6.9%) higher with CAFF
ingestion compared with the placebo condition (P = .034;
ES = 0.35; 95% CI, 0.03 to 0.66; Figure 2A). In addition, CMJ
height was improved by 4.2% (5.2%) with CAFF compared with
the placebo (P = .006; ES = 0.22; 95% CI, 0.08 to 0.37; Figure 2B).
SV and MATT
The time required to complete the SV was −1.6% (2.6%) lower
with CAFF compared with the placebo (P = .042; ES = −0.34; 95%
CI, −0.66 to −0.01; Figure 2C). However, no statistical differences
were reported between treatments in the MATT (P = .669; ES =
−0.08; 95% CI, −0.49 to 0.33; Figure 2D).
Figure 1 — Ball velocity in several throwing tests in elite female
handball players with the administration of 3 mg/kg/bm of caffeine or a
placebo. bm indicates body mass; BT, ball throw; GT, goalkeeper.
*Significant differences compared with placebo values at P < .05.
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Simulated Handball Match
Compared to the placebo, CAFF increased the overall frequency of
accelerations during the simulated match (18.1 [1.2] vs 18.8
[1.0] number/min; P = .044; ES = 0.54; 95% CI, 0.02 to 1.07).
Specifically, CAFF increased the number of accelerations in zone 3
(P = .002; ES = 0.94; 95% CI, 0.39 to 1.48; Figure 3) with no
differences in zones 1, 2, and 4 (P = .115–.725). CAFF also
increased the overall frequency of decelerations (18.0 [1.2] vs
18.7 [1.0] number/min; P = .032; ES = 0.56; 95% CI, 0.06 to 1.06),
reported statistical differences in zone 3 (P = .039; ES = 0.30; 95%
CI, 0.02 to 0.59) (Figure 4), whereas no differences were obtained
in zones 1, 2, and 4 (P = .106–.298). In addition, CAFF increased
the overall frequency of body impacts (20 [8] vs 22 [10] impacts/
min; P = .032; ES = 0.30; 95% CI, 0.03 to 0.52). This ergogenic
effect was evident in zone 1 (P = .037; ES = 0.20; 95% CI, 0.01
to 0.38) and zone 3 (P = .004; ES = 1.17; 95% CI, 0.44 to 1.89)
(Figure 5) with no effect in zone 2 (P = .075; ES = 0.36; 95% CI,
−0.04 to 0.76). CAFF also increased maximal (185 [5] vs
189 [5] beats/min; P = .018; ES = 0.36; 95% CI, 0.08 to 0.65)
and mean heart rate during the match (157 [21] vs 166 [16] beats/
min; P = .035; ES = 0.37; 95% CI, 0.03 to 0.70). Finally, no
differences were reported between conditions in the total distance
covered (72 [17] vs 74 [15] m/min; P = .519; ES = 0.06; 95% CI,
Figure 2 — The IHS, CMJ height, 30-m running time (SV), and time employed to complete a MATT in elite female handball players with the
administration of 3 mg/kg/bm of caffeine or a placebo. bm indicates body mass; CMJ, countermovement jump; IHS, isometric handgrip strength; MATT,
modified version of the agility T test. *Significant differences compared with placebo values at P < .05.
Figure 3 — Frequency of accelerations in different intensity zones
(zone 1 [0–1 m/s2], zone 2 [1–2 m/s2], zone 3 [2–3 m/s2], and zone 4
[3–4 m/s2]) during a simulated handball match in elite female handball
players with the administration of 3 mg/kg/bm of caffeine or a placebo. bm
indicates body mass. *Significant differences compared with placebo
values at P < .05.
Figure 4 — Frequency of decelerations in different intensity zones
(zone 1 [0 to −1 m/s2], zone 2 [−1 to −2 m/s2], zone 3 [−2 to −3 m/s2],
and zone 4 [−3 to −4 m/s2]) during a simulated handball match in elite
female handball players with the administration of 3 mg/kg/bm of caffeine
or a placebo. bm indicates body mass. *Significant differences compared
with placebo values at P < .05.
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−0.13 to 0.26), the distance covered at sprint velocity (8.57 [3.17]
vs 7.97 [2.86] m/min; P = .164; ES = 0.20; 95% CI,−0.09 to
0.49), and the maximal running speed attained during the game
(18.6 [1.72] vs 19.0 [2.07] km/h; P = .273; ES = 0.21; 95% CI,
−0.19 to 0.62).
Prevalence of Side Effects
During the testing, the handball players reported similar self-
perceived endurance (CAFF = 6.4 [2.5] vs placebo = 6.0 [1.65]
point; P = .420), muscle power (5.87 [2.20] vs 5.73 [1.22] points;
P = .820), and fatigue (5.20 [2.60] points vs 5.53 [2.07] points;
P = .950). During the hours after the testing, the handball players
showed a similar prevalence of side effects (insomnia, gastrointes-
tinal problems, activeness, irritability, muscular pain, tachycardia
and heart palpitations, headache, urine excretion, fatigue, and
nervousness) between the 2 experimental protocols (Table 1).
Only 33.3% (5 out of 15) participants correctly guessed the order
of the trials, indicating successful blinding of the participants to the
interventions.
Discussion
Although the ergogenicity of CAFF has been previously proven in
several team sports,14,15,17 only one study has evaluated the effects
of this substance in handball.7 Consequently, there is a need to
understand how CAFF can impact physical performance of hand-
ball players to ascertain if this substance might be beneficial to
increase overall handball performance. Following this lack of
information, the purpose of the present study was to determine
the effect of preexercise CAFF intake on handball-specific physical
performance. In comparison with the placebo, CAFF increased ball
velocity in throws of 7 m, 7 m with GK, 9 m, and 9 m with GK
(2.2%–3.6%); enhanced IHS (3.3%); and CMJ height (4.2%) while
it decreased the time needed to complete a 30-m sprint (−1.6%).
Contrary to our hypothesis, CAFF did not affect the time employed
to complete the MATT. To increase the application of this study, in
addition to the physical testing, participants competed in a simu-
lated match, and CAFF was effective to increase the total number
of accelerations (3.9%) and decelerations (4.0%), per minute
together with an increase in the total number of body impacts
(12.4%). However, the total distance covered during the match and
the maximal running speed attained during the match were unaf-
fected by CAFF. All these results indicate that CAFF, in a dose of
3 mg/kg/bm, might be considered as an ergogenic aid for elite
women handball players because it has the capacity of enhancing
BT velocity, jump and sprint performance, and the frequency of in-
game accelerations and decelerations.
In handball, a BT to goal is a common and determinant
attacking skill which allows players to score. In addition to
precision, a critical characteristic of this complex skill is the
velocity at which the ball is thrown.33 To assess the effect of
CAFF on this skill, a set of several ball throwing tests was
designed. The battery of throws included attempts at varying
distances (7 vs 9 m), with/without the presence of a GK and
with different approaches (none or a 3-step run). Independently of
the characteristics of the throw, CAFF improved maximal ball
velocity by 2.0% to 3.3%. Interestingly, the highest increase in
BT velocity was found in the throws performed with an approxi-
mation to the line of 9 m (3.0%–3.3%), indicating a key effect
of CAFF to increase the capacity for throwing during in-game
actions. Although no previous studies have analyzed the effect of
3 mg/kg/bm of CAFF on BT in handball players, the effectiveness
of this substance has also been shown in other manifestations of
muscle power in the upper body such as spikes in volleyball15 and
the tennis serve.34 Thus, the ingestion of a low dose of CAFF before
a match might be effective to increase ball velocity in elite handball
players.
In comparison with the placebo, IHS was improved by 3.3% in
the dominant hand with the ingestion of CAFF. This effect was
slightly lower to those previously reported in other intermittent
sports such as volleyball or tennis (4.4%–10.8%).15,35 Although
handgrip is not a specific action of handball match play, this test is a
simple method to test the effect of CAFF on force production and
might be indicative of a higher capacity to produce force during
game actions. In addition, handgrip strength has a strong correla-
tion with ball velocity and might be one of the reasons for the
increased ball velocity obtained with CAFF.36 Likewise, vertical
jumps, which are commonly executed to throw and to block rivals’
attempts on goal37 was improved with CAFF intake (4.2%).
Figure 5 — Frequency of body impacts in different intensity zones
(zone 1 [0 to ≤5] g; zone 2 [5 to ≤8 g]; and zone 3 [8 to ≤10 g]) during a
simulated handball match in elite female handball players with the
administration of 3 mg/kg/bm of caffeine or a placeboQ19 . bm indicates
body mass. *Significant differences compared with placebo values at
P < .05.
Table 1 Prevalence of Side Effects Reported in the
Morning After the Ingestion of 3 mg of Caffeine Per
Kilogram of Body Mass or Placebo
Items Placebo Caffeine P
Insomnia, % 20.0 66.7 .065
Gastrointestinal problems, % 6.6 26.6 .250
Increased activeness, % 13.3 20.0 1.000
Irritability, % 46.6 26.6 .375
Muscular pain, % 46.6 46.6 1.000
Tachycardia and heart palpitations, % 6.6 13.3 1.000
Headache, % 20.0 40.0 .453
Increased excretion of urine, % 26.6 40.0 .687
Increased fatigue 6.6 6.0 .554
Nervousness 4.4 4.0 .326
Note: Data are percentage of affirmative responses to each of the side effects
obtained from 15 elite female handball players.
(Ahead of Print)
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According to previous literature, CAFF ingestion (3–6 mg/kg/bm)
enhances jump height by 2.8% to 7.3% in different vertical jump
protocols in elite women athletes of other intermittent sports such
as volleyball,15 rugby sevens,14 or football players.17 In addition, a
recent meta-analysis carried out by Grgic et al,38 who included 10
investigations about CAFF effect on muscle power expressed as
vertical jump height, indicated that acute CAFF intake enhanced
jump height with a standardized mean difference of 0.17, which is
similar to the magnitude of the ergogenic effect of CAFF on CMJ
height found in the current investigation. This informationQ20 indi-
cates that preexercise CAFF ingestion enhances muscle force and
power that might be indicative of an improved handball physical
performance.
During handball matches, the number and velocity of the
sprints performed are critical for success.2 To fulfill the aim of
this investigation, we selected a 30-m maximal running test and an
adapted version of the T test (MATT) to verify the effect of CAFF
on speed and agility. The results indicate that CAFF reduced sprint
time by 1.6%, while the effect of this stimulant was not statistically
significant to reduce the time necessary to complete the MATT
(−0.5%). Other studies that used similar CAFF doses in team sports
players have found that CAFF is effective to increase running speed
in single and repeated sprint actions.12 In addition, it seems that
CAFF ergogenicity in maximal running sport-specific testing
might be transferred to improve movement patterns at sprint
velocity during a simulated match.14 In the current investigation,
the higher sprint velocity during the 30-m sprint test was not
accompanied by a higher running distance at sprint velocity during
the match between placebo and CAFF ingestion (7.97 vs 8.57 m/min,
respectively). It is likely that the court dimensions and the presence of
adversaries limited the transference of the ergogenic effect of CAFF
from the SV to the sprints performed during the match. Thus, while it
seems proven that CAFFmight be effective to increase running speed
and agility in team sport-specific testing,12 more information is
required to verify whether this effect is transferred to in-game sprint
actions during a handball match.
To our knowledge, this is the first study to analyze the effects
of CAFF intake (3 mg/kg/bm) on handball in-game performance
using ultra-wideband tracking system technology devices. CAFF
increased the number of accelerations and decelerations per minute
by 3.9% and 4.0%, respectively, with a concomitant positive effect
on body impacts. This effect could be related to a better mainte-
nance of physical performance during the game as the frequency of
these high-intensity actions decreases across the match.4 However,
no differences were observed in total distance covered, the distance
covered in different speed zones or the maximal speed reached
during the match. Since the numberQ21 of high-intensity actions,
such as accelerations, decelerations, and body impacts are crucial
in handball performance,2 because they represent fast changes
of direction, running sprints, and collisions with opponents,
our results seem to support the ergogenic effect of CAFF on
handball in-game performance, as previously found in other
team sports.13–15 Although the measurement of body accelera-
tions/decelerations and impacts is unspecific to differentiate among
different handball actions, the higher frequency of these actions
with the ingestion of CAFF suggests that this substance might be
able to augments the number of changes of directions and the
quantity of blocks (produced or received) and sprints.
Finally, the results of postmatch surveys about self-reported
feelings did not indicate any difference between CAFF or placebo
ingestion. Nevertheless, a tendency for increased prevalence of
insomnia was evident with CAFF over the placebo, as previously
found.21 Thus, attention should be paid to the use of this substance
when 2 games are played on consecutive days or when training
routines are carried out in the afternoon.
The current investigation has several limitations. First, the
simulated game was shorter than an official handball game, and
further investigations should determine the effect of CAFF in real
competitive scenarios. Second, the dietary patterns before the first
experimental trial, including avoidance of dietary sources of
CAFF, were recorded and replicated in the second experimental
sessions while the obtaining of urine samples might have helped to
certify that all players had complied with the removal of CAFF
from their diets. Q23Finally, the findings of this study should only be
translated to elite female handball players unhabituated to CAFF
who are willing to use 3 mg/kg of CAFF to increase the perfor-
mance, as tolerance, dose, and sex might significantly affect the
positive effect of CAFF.39,40
Practical Applications
The results of this investigation showed that 3 mg/kg/bm of CAFF
might be catalogued as a useful strategy for improving physical
performance in elite women handball players and for enhancing
handball performance during a simulated match. However, despite
these positive outcomes, CAFF should be recommended on an
individual basis, after careful evaluation of potential drawbacks
and after experimenting its effects during training. CAFF should
not be recommended to those who do not positively respond to
acute CAFF intake, those who report side effects such insomnia, or
those who are not willing to use stimulants to increase sports
performance.
Conclusion
The ingestion of 3 mg/kg/bm of CAFF improved jump height,
sprint speed, handgrip force, BT velocity, as well as accelerations,
decelerations, and body impacts during a simulated handball game
in elite women handball players.
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quierdo M. Effects of an entire season on physical fitness changes
in elite male handball players. Med Sci Sports Exerc. 2006;38(2):
357–366. doi:10.1249/01.mss.0000184586.74398.03
7. Ribeiro BG, Morales AP, Sampaio-Jorge F, et al. Caffeine attenuates
decreases in leg power without increased muscle damage. J Strength
Cond Res. 2016;30(8):2354–2360. PubMed ID: 26808856 doi:10.
1519/JSC.0000000000001332
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